Email Alert RSS
Volume 13 Issue 6
Nov.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
XU Fen, ZHOU Zhou. Heart Failure: Prevention and Treatment are Indispensable[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 953-957. DOI: 10.12290/xhyxzz.2022-0440
Citation: XU Fen, ZHOU Zhou. Heart Failure: Prevention and Treatment are Indispensable[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 953-957. DOI: 10.12290/xhyxzz.2022-0440
shu

Heart Failure: Prevention and Treatment are Indispensable

  • Center of Laboratory Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing 100037, China

More Information
  • Corresponding author:

    ZHOU Zhou, E-mail: zhouzhou@fuwaihospital.org

  • Received Date: August 09, 2022
  • Accepted Date: October 15, 2022
  • Available Online: October 16, 2022
  • Issue Publish Date: November 29, 2022
    Graphical Abstract
    • Abstract
  • Recently, 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure has been published. It advocates to pay equal attention to the prevention and treatment of heart failure; and emphasizes that primary prevention based on natriuretic peptides screening is essential for patients at risk for heart failure or with pre-heart failure. Furthermore, it recommends that patients with symptomatic heart failure should receive care from a multidisciplinary team to facilitate the implementation of "basic quadruple therapy" including sodium glucose cotransporter 2 inhibitors; and that patients with advanced heart failure who wish to prolong their survival should be timely referral for heart failure specialty care and assess suitability for advanced heart failure therapies.
    • FullText(HTML)
    • References (16)
  • [1]
    Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145: e895-e1032.
    [2]
    《心力衰竭通用定义和分类》将开启心力衰竭诊疗的标准化进程[J]. 协和医学杂志, 2021, 12: 621-623.
    [3]
    McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42: 3599-3726. DOI: 10.1093/eurheartj/ehab368
    [4]
    Faggiano P, Bernardi N, Calvi E, et al. Stage A Heart Failure: Modern Strategies for an Effective Prevention[J]. Heart Fail Clin, 2021, 17: 167-177. DOI: 10.1016/j.hfc.2021.01.004
    [5]
    Redfield MM. Strategies to screen for stage B as a heart failure prevention intervention[J]. Heart Fail Clin, 2012, 8: 285-296. DOI: 10.1016/j.hfc.2011.12.001
    [6]
    Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 62: e147-e239. DOI: 10.1016/j.jacc.2013.05.019
    [7]
    Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J]. Circulation, 2017, 136: e137-e161.
    [8]
    Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2019, 140: e596-e646.
    [9]
    Ledwidge M, Gallagher J, Conlon C, et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial[J]. JAMA, 2013, 310: 66-74. DOI: 10.1001/jama.2013.7588
    [10]
    Huelsmann M, Neuhold S, Resl M, et al. PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial[J]. J Am Coll Cardiol, 2013, 62: 1365-1372. DOI: 10.1016/j.jacc.2013.05.069
    [11]
    Suthahar N, Lau ES, Blaha MJ, et al. Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers with Incident Heart Failure[J]. J Am Coll Cardiol, 2020, 76: 1455-1465. DOI: 10.1016/j.jacc.2020.07.044
    [12]
    Bozkurt B. It Is Time to Screen for Heart Failure: Why and How?[J]. JACC Heart Fail, 2022, 10: 598-600. DOI: 10.1016/j.jchf.2022.06.001
    [13]
    McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2019, 381: 1995-2008. DOI: 10.1056/NEJMoa1911303
    [14]
    Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure[J]. N Engl J Med, 2020, 383: 1413-1424. DOI: 10.1056/NEJMoa2022190
    [15]
    Zannad F, Ferreira JP, Pocock SJ, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials[J]. Lancet, 2020, 396: 819-829. DOI: 10.1016/S0140-6736(20)31824-9
    [16]
    Sharma A, Verma S, Bhatt DL, et al. Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?[J]. JACC Basic Transl Sci, 2022, 7: 504-517.
    • Related Articles

  • Related Articles

    [1]ZHOU Yongtai, YANG Zhenyu, LI Yan, WU Jiajing, ZHAO Bo. Research Progress on the Mechanism of Lipocalin-2 in Neurological Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 330-337. DOI: 10.12290/xhyxzz.2025-0028
    [2]ZENG Xinying, WEN Xuejun, GUO Zhide, ZHANG Xianzhong. Advances in Synergistic Antitumor Effects of Radiopharmaceuticals Combined with Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 680-690. DOI: 10.12290/xhyxzz.2023-0159
    [3]WEI Jiaojiao, LIU Shiwei, DUAN Ruixue, LI Nan, WANG Jiangna. Effects of Vaspin on Pancreatic Beta Cell Function in Type 2 Diabetic Rats by AMPK/mTOR Autophagy Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 543-552. DOI: 10.12290/xhyxzz.2022-0183
    [4]LI Yi, XU Yingchun. A New Chapter in the COVID-19 Pandemic: the Characteristics of Omicron Variant and A New Step for Scientific Epidemic Prevention and Control[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 9-17. DOI: 10.12290/xhyxzz.2022-0697
    [5]Huai-ya XIE, Chao LI, Yu-bing WEN, Wei YE, Jian-fang CAI, Hang LI, Xue-mei LI, Xue-wang LI. Efficacy and Prognosis of Calcineurin inhibitors and Cyclophosphamide in Treating Idiopathic Membranous Nephropathy in Patients with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 296-300. DOI: 10.3969/j.issn.1674-9081.20180463
    [6]Zheng-huan LIU, Liang ZHOU, Zhi-hong LIU, Tao CHEN, Jia-qi LI, Kun-jie WANG, Hong LI, Yu-chun ZHU. Changes in Postoperative Blood Glucose and the Predictive Factors in Patients with Pheochromocytoma Complicated with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 342-345. DOI: 10.3969/j.issn.1674-9081.2018.04.010
    [7]Peng-ju LIU, Fang MA, Ming LI, Jie LU. Effects of Inulin and Chicory on Glucose Control and Lipid Profiles in Patients with Type 2 Diabetes[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(4): 251-254. DOI: 10.3969/j.issn.1674-9081.2015.04.003
    [8]Jia-yu ZHANG, Fang MA, Peng-ju LIU, Shu-li HE, Jing-hui FANG. Influence of Different Staple Food Compositions on Blood Glucose and Lipid in Patients with Type 2 Diabetes Mellitus[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(4): 241-245. DOI: 10.3969/j.issn.1674-9081.2015.04.001
    [9]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
    [10]Xiao-hua SHI, Zhi-yong LIANG, Huan-wen WU, Xin-yu REN, Tong-hua LIU. Effect of RNA Interference Plasmid on the Expression of Oncogene AKT2 in Pancreatic Cancer Cell Line Panc-1[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 102-108. DOI: 10.3969/j.issn.1674-9081.2012.01.021

  • Cited by

    Periodical cited type(2)

    1. 王敏，张晶，张雪峰，杨皎，宋一亭. 宋一亭从肾阳虚论治慢性心力衰竭经验. 内蒙古中医药. 2024(08): 78-80 .
    2. 刘梦君，于秋雨，陈易珠，李彩霞，刘福明. 基于《2022年AHA/ACC/HFSA心力衰竭管理指南》分期探讨“四防”理念及辨治. 环球中医药. 2023(12): 2479-2482 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (482) PDF downloads (96) Cited by(5)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close